Pfizer, BioNTech Seek Emergency COVID-19 Vaccine Approval
Pfizer and its German partner BioNTech filed an emergency approval request with the U.S. Food and Drug Administration on Friday, asking the regulator to sign off on their COVID-19 vaccine candidate,...To view the full article, register now.
Already a subscriber? Click here to view full article